Latest Restructuring News

Ten Sixty Four Limited has revealed a staggering net loss of US$43 million for the year ended June 2024, alongside a sharp 94% revenue decline and a modified audit opinion, raising fresh questions about its financial stability.

Lithium Energy Limited has secured unconditional shareholder approval for the amended sale of its Solaroz Lithium Brine Project, with completion now staged over two tranches through January 2026. Meanwhile, the company prepares for the Axon Graphite spin-out IPO, navigating an ongoing ASX trading suspension due to operational thresholds.

Newfield Resources Limited reports a strategic pivot for its Tongo Diamond Mine, engaging a joint development partner to reduce costs and delay bulk sampling amid a depressed diamond market.

Australian Oil Company Limited (AOK) reports significant progress in its California pipeline acquisition and appoints Chris Hodge as Non-Executive Chairman, signaling a strategic push into US gas exploration.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

AssetOwl Limited has appointed new directors and secured a $300,000 loan facility as it undertakes a strategic review to revive shareholder value amid a quiet quarter.

DMC Mining Limited progresses its strategic acquisition of the Firawa and Labé uranium projects in Guinea, while navigating key board appointments and capital raising efforts ahead of ASX re-admission.

Field Solutions Holding Ltd reported a positive net cash flow from operations for the December quarter but faces significant investing outflows and is currently in voluntary suspension pending a capital raise.

Strandline Resources reports a decline in mineral sands production and sales in the December 2024 quarter, impacted by lower ore grades and mechanical setbacks, while actively negotiating debt restructuring and advancing key infrastructure projects.

Atomos Limited reported a 7% increase in Q2 FY25 sales driven by its core Shinobi II product, but faced margin pressures due to discounting and competitive pricing. The company is finalizing a cost restructure and reviewing funding options to support future growth.

Cardiex has kicked off deliveries of its CONNEQT Pulse arterial health monitors in the U.S., reporting strong preorder momentum and a 150% sales increase in December. The company’s strategic operational shifts and pharma partnerships set the stage for sustained growth in 2025.

LawFinance Limited has completed a significant debt restructuring, easing financial pressures, but faces ongoing challenges with declining cash collections and uncertain progress on its Trident Health Group initiative.